Exact Mass: 417.20120920000005
Exact Mass Matches: 417.20120920000005
Found 188 metabolites which its exact mass value is equals to given mass value 417.20120920000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
6-Methyl-1'-(2-(5-methyl-2-phenyloxazol-4-yl)ethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one
C25H27N3O3 (417.20523120000007)
3alpha,6beta-dicinnamoyloxytropane
C26H27NO4 (417.19399820000007)
Hexanoic acid, 2-hydroxy-2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide
C25H27N3O3 (417.20523120000007)
(-)-8beta-(4-hydroxybenzyl)-2,3-dimethoxyberbin-10-ol
C26H27NO4 (417.19399820000007)
Ala Ala Ala Trp
C20H27N5O5 (417.20120920000005)
Ala Ala Trp Ala
C20H27N5O5 (417.20120920000005)
Ala Cys Lys Pro
C17H31N5O5S (417.20457960000005)
Ala Cys Pro Lys
C17H31N5O5S (417.20457960000005)
Ala Asp Gly Arg
Ala Asp Arg Gly
Ala Gly Asp Arg
Ala Gly Arg Asp
Ala Lys Cys Pro
C17H31N5O5S (417.20457960000005)
Ala Lys Pro Cys
C17H31N5O5S (417.20457960000005)
Ala Pro Cys Lys
C17H31N5O5S (417.20457960000005)
Ala Pro Lys Cys
C17H31N5O5S (417.20457960000005)
Ala Arg Asp Gly
Ala Arg Gly Asp
Ala Trp Ala Ala
C20H27N5O5 (417.20120920000005)
Cys Ala Lys Pro
C17H31N5O5S (417.20457960000005)
Cys Ala Pro Lys
C17H31N5O5S (417.20457960000005)
Cys Lys Ala Pro
C17H31N5O5S (417.20457960000005)
Cys Lys Pro Ala
C17H31N5O5S (417.20457960000005)
Cys Pro Ala Lys
C17H31N5O5S (417.20457960000005)
Cys Pro Lys Ala
C17H31N5O5S (417.20457960000005)
Asp Ala Gly Arg
Asp Ala Arg Gly
Asp Gly Ala Arg
Asp Gly Arg Ala
Asp Arg Ala Gly
Asp Arg Gly Ala
Glu Gly Gly Arg
Glu Gly Arg Gly
Glu Arg Gly Gly
Gly Ala Asp Arg
Gly Ala Arg Asp
Gly Asp Ala Arg
Gly Asp Arg Ala
Gly Glu Gly Arg
Gly Glu Arg Gly
Gly Gly Glu Arg
Gly Gly Arg Glu
Gly Gly Val Trp
C20H27N5O5 (417.20120920000005)
Gly Gly Trp Val
C20H27N5O5 (417.20120920000005)
Gly Arg Ala Asp
Gly Arg Asp Ala
Gly Arg Glu Gly
Gly Arg Gly Glu
Gly Val Gly Trp
C20H27N5O5 (417.20120920000005)
Gly Val Trp Gly
C20H27N5O5 (417.20120920000005)
Gly Trp Gly Val
C20H27N5O5 (417.20120920000005)
Gly Trp Val Gly
C20H27N5O5 (417.20120920000005)
Lys Ala Cys Pro
C17H31N5O5S (417.20457960000005)
Lys Ala Pro Cys
C17H31N5O5S (417.20457960000005)
Lys Cys Ala Pro
C17H31N5O5S (417.20457960000005)
Lys Cys Pro Ala
C17H31N5O5S (417.20457960000005)
Lys Pro Ala Cys
C17H31N5O5S (417.20457960000005)
Lys Pro Cys Ala
C17H31N5O5S (417.20457960000005)
Pro Ala Cys Lys
C17H31N5O5S (417.20457960000005)
Pro Ala Lys Cys
C17H31N5O5S (417.20457960000005)
Pro Cys Ala Lys
C17H31N5O5S (417.20457960000005)
Pro Cys Lys Ala
C17H31N5O5S (417.20457960000005)
Pro Lys Ala Cys
C17H31N5O5S (417.20457960000005)
Pro Lys Cys Ala
C17H31N5O5S (417.20457960000005)
Arg Ala Asp Gly
Arg Ala Gly Asp
Arg Asp Ala Gly
Arg Asp Gly Ala
Arg Glu Gly Gly
Arg Gly Ala Asp
Arg Gly Asp Ala
Arg Gly Glu Gly
Arg Gly Gly Glu
Val Gly Gly Trp
C20H27N5O5 (417.20120920000005)
Val Gly Trp Gly
C20H27N5O5 (417.20120920000005)
Val Trp Gly Gly
C20H27N5O5 (417.20120920000005)
Trp Ala Ala Ala
C20H27N5O5 (417.20120920000005)
Trp Gly Gly Val
C20H27N5O5 (417.20120920000005)
Trp Gly Val Gly
C20H27N5O5 (417.20120920000005)
Trp Val Gly Gly
C20H27N5O5 (417.20120920000005)
N,N-DIMETHYL-4-((4-((4-((TRIMETHYLSILYL)ETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)ANILINE
C29H27NSi (417.19126620000003)
3-Pyridinecarboxaldehyde, 5-ethenyl-4-[4-fluoro-2-(phenylmethoxy)phenyl]-2,6-bis(1-methylethyl)-
4-Nitrophenyl phosphate bis(cyclohexylammonium) salt
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride
cyclohexanamine,(3-nitrophenyl) dihydrogen phosphate
Benzenepropanoic acid, 4,4-(phenylimino)bis-,1,1-dimethyl ester
C26H27NO4 (417.19399820000007)
6-Chloro-1-methyl-2,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
C21H30B2ClNO4 (417.2049350000001)
(5-acetamido-3,4-diacetyloxy-6-pentoxyoxan-2-yl)methyl acetate
C19H31NO9 (417.19987160000005)
TEGASEROD MALEATE
C20H27N5O5 (417.20120920000005)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tegaserod maleate (SDZ-HTF-919) is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod maleate has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod maleate causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. Tegaserod maleate has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research[1][2][3].
Naphthalen-1-yl-(5-naphthalen-1-yl-1-pentylpyrrol-3-yl)methanone
N-[6-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-3-yl]hex-4-ynyl]methanesulfonamide
C23H31NO4S (417.19736860000006)
beta-Aminoarteether maleate
C19H31NO9 (417.19987160000005)
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
Asp-Gln-Arg
A tripeptide composed of L-aspartic acid, L-glutamine and L-arginine joined in sequence by peptide linkages.
3-[1-[Oxo-(1-phenylcyclopentyl)methyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one
C25H27N3O3 (417.20523120000007)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
C17H31N5O5S (417.20457960000005)
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27N3O3 (417.20523120000007)
2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide (2Z)-but-2-enedioic acid
C20H27N5O5 (417.20120920000005)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists
4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-(morpholin-4-yl)phenyl]pyrimidin-2-amine
2-N-[(1R)-1-[4-(4-methoxyphenoxy)phenyl]ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine
2-(2-methylindol-1-yl)-1-[(2S)-2-(piperidine-1-carbonyl)-2,3-dihydro-1,4-benzoxazin-4-yl]ethanone
C25H27N3O3 (417.20523120000007)
RS504393
C25H27N3O3 (417.20523120000007)
Ansofaxine hydrochloride
Ansofaxine hydrochloride (LY03005; LPM570065) is a triple reuptake inhibitor; inhibits serotonin, dopamine and norepinephrine reuptake with IC50 values of 723, 491 and 763 nM, respectively.
7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-4,8-dimethoxy-1,3-dimethylisoquinoline
C26H27NO4 (417.19399820000007)
5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-6,8-dimethoxy-1,3-dimethylisoquinoline
C26H27NO4 (417.19399820000007)